Pfizer Divests Hospira Infusion Systems To ICU, Retaining An Interest In The Acquier

Pfizer Inc. (NYSE: PFE) recently announced that it has entered into definitive agreement with ICU Medical (NASDAQ: ICUI) to sell its infusion systems business, which it had received via the acquisition of Hospira last year. The deal is expected to close in first quarter of 2017. The small medical device business in infusions is an outlier within Pfizer’s very large pharmaceutical portfolio and its divestiture makes sense. But, the nature of this transaction makes it more of investment rather t...